Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Beta Bionics, Inc.NASDAQ: BBNX
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$391.83M, compared with -$325.39M a year earlier.
Context
- Retained earnings amounted to 128.7% of total assets at the end of Q1 FY2026, up 32.5 pp from a year earlier.
- Retained earnings grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -20.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (369.94M) USD
- Year-over-year change
- -24.7%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (369.94M) | -24.7% |
| FY2024 | 2024-12-31 | (296.74M) | -29.2% |
| FY2023 | 2023-12-31 | (229.66M) | -23.8% |
| FY2022 | 2022-12-31 | (185.57M) | — |
Retained Earnings vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -20.4% is the lowest of 7, against a peer median of +44.7%.
- Retained earnings amounts to 128.7% of total assets for BBNX, versus a peer median of 37.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 224.16B DKK | +36.3% | +34.3% | 37.7% | |
| Jun 2026 | $2.88B USD | +53.1% | +71.8% | 44.7% | |
| Jun 2026 | $473.5M USD | +382.2% | — | 15.0% | |
| Mar 2026 | -$85.12M USD | +53.8% | — | 31.7% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | -$116M USD | — | — | 2.5% |
| Mar 2026 | -$391.83M USD | -20.4% | — | 128.7% | |
| Mar 2026 | -$1.27B USD | -8.0% | — | 110.4% | |
| Mar 2026 | -$3.21B USD | -0.7% | — | 431.6% | |
| Peer median (excluding BBNX) | — | +44.7% | +53.1% | 37.7% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.